Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Antiviral medications for pregnant women for pandemic and seasonal influenza: an economic computer model.

Lee BY, Bailey RR, Wiringa AE, Assi TM, Beigi RH.

Obstet Gynecol. 2009 Nov;114(5):971-80. doi: 10.1097/AOG.0b013e3181bdbfed.

2.

Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant.

Yates L, Pierce M, Stephens S, Mill AC, Spark P, Kurinczuk JJ, Valappil M, Brocklehurst P, Thomas SH, Knight M.

Health Technol Assess. 2010 Jul;14(34):109-82. doi: 10.3310/hta14340-02.

3.

The cost effectiveness of pandemic influenza interventions: a pandemic severity based analysis.

Milne GJ, Halder N, Kelso JK.

PLoS One. 2013 Apr 9;8(4):e61504. doi: 10.1371/journal.pone.0061504. Print 2013.

4.

Economic value of seasonal and pandemic influenza vaccination during pregnancy.

Beigi RH, Wiringa AE, Bailey RR, Assi TM, Lee BY.

Clin Infect Dis. 2009 Dec 15;49(12):1784-92. doi: 10.1086/649013.

5.

Influenza infection and vaccination in pregnant women.

Tamma PD, Steinhoff MC, Omer SB.

Expert Rev Respir Med. 2010 Jun;4(3):321-8. doi: 10.1586/ers.10.26. Review.

PMID:
20524915
6.

Economic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities.

Risebrough NA, Bowles SK, Simor AE, McGeer A, Oh PI.

J Am Geriatr Soc. 2005 Mar;53(3):444-51.

PMID:
15743287
7.

Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK.

Sander B, Hayden FG, Gyldmark M, Garrison LP Jr.

Pharmacoeconomics. 2006;24(4):373-86.

PMID:
16605283
8.

[Cost-effectiveness of vaccinating pregnant women against pandemic influenza in Colombia].

Chocont√°-Piraquive LA, Alvis Guzm√°n N, De la Hoz Restrepo F.

Rev Panam Salud Publica. 2012 Jun;31(6):447-53. Spanish.

9.

Economic model for emergency use authorization of intravenous peramivir.

Lee BY, Tai JH, Bailey RR, McGlone SM, Wiringa AE, Zimmer SM, Smith KJ, Zimmerman RK.

Am J Manag Care. 2011 Jan;17(1):e1-9.

10.

Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model.

Sander B, Nizam A, Garrison LP Jr, Postma MJ, Halloran ME, Longini IM Jr.

Value Health. 2009 Mar-Apr;12(2):226-33. doi: 10.1111/j.1524-4733.2008.00437.x. Epub 2008 Jul 30.

11.

An incremental economic evaluation of targeted and universal influenza vaccination in pregnant women.

Skedgel C, Langley JM, MacDonald NE, Scott J, McNeil S.

Can J Public Health. 2011 Nov-Dec;102(6):445-50.

PMID:
22164556
12.

Antiviral agents for influenza: a comparison of cost-effectiveness data.

Lynd LD, Goeree R, O'Brien BJ.

Pharmacoeconomics. 2005;23(11):1083-106. Review.

PMID:
16277546
13.

Seasonal influenza vaccination during pregnancy and the risks of preterm delivery and small for gestational age birth.

Ahrens KA, Louik C, Kerr S, Mitchell AA, Werler MM.

Paediatr Perinat Epidemiol. 2014 Nov;28(6):498-509. doi: 10.1111/ppe.12152. Epub 2014 Oct 21.

14.

Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic.

Khazeni N, Hutton DW, Garber AM, Owens DK.

Ann Intern Med. 2009 Dec 15;151(12):840-53. doi: 10.7326/0003-4819-151-12-200912150-00156.

15.

Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories.

Kelso JK, Halder N, Postma MJ, Milne GJ.

BMC Public Health. 2013 Mar 8;13:211. doi: 10.1186/1471-2458-13-211.

16.

To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling.

Lee BY, McGlone SM, Bailey RR, Wiringa AE, Zimmer SM, Smith KJ, Zimmerman RK.

PLoS One. 2010 Jun 23;5(6):e11284. doi: 10.1371/journal.pone.0011284.

17.

Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation.

Tappenden P, Jackson R, Cooper K, Rees A, Simpson E, Read R, Nicholson K.

Health Technol Assess. 2009 Feb;13(11):iii, ix-xii, 1-246. doi: 10.3310/hta13110. Review.

18.

Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy.

Myers ER, Misurski DA, Swamy GK.

Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S128-40. doi: 10.1016/j.ajog.2011.04.009. Epub 2011 Apr 15. Review.

PMID:
21640230
19.

Review of the pandemic (H1N1) 2009 among pregnant Japanese women.

Nakai A, Saito S, Unno N, Kubo T, Minakami H.

J Obstet Gynaecol Res. 2012 May;38(5):757-62. doi: 10.1111/j.1447-0756.2011.01812.x. Epub 2012 Apr 9. Review.

PMID:
22487092
20.

Influenza during pregnancy: a cause of serious infection in obstetrics.

Beigi RH.

Clin Obstet Gynecol. 2012 Dec;55(4):914-26. doi: 10.1097/GRF.0b013e31827146bd.

PMID:
23090460

Supplemental Content

Support Center